Umakanth Vudumula (U Vudumula)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Systemic Lupus Erythematosus

Multiple Sclerosis

Health Insurance

Top Venues

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Umakanth Vudumula, Mausam Patidar, Kapil Gudala, Elizabeth Karpf, Nicholas Adlard
Evaluating the impact of early vs delayed ofatumumab initiation and estimating the long-term outcomes of ofatumumab vs teriflunomide in relapsing multiple sclerosis patients in Spain. Journal of medical economics (2022)
Stephen Maxwell Montgomery, Fern Amy Woodhouse, Umakanth Vudumula, K Gudala, Martin Edward Duddy, M Kroes
Stick or twist? Cost-effectiveness of siponimod compared with continuing existing disease-modifying therapies in the treatment of active secondary progressive multiple sclerosis in the UK. Journal of medical economics 25 (1) (2022)
Hamid Reza Nakhaipour, Umakanth Vudumula, Vivek Khurana, Guillaume Sébire, Jean K Mah, Daniela Pohl, Robyn Schecter, Nicholas Adlard
Cost-effectiveness of fingolimod versus interferon-β1a for the treatment of pediatric-onset multiple sclerosis in Canada. Journal of medical economics 23 (12) (2020)